William Walsh
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Biotechnology top 1%
- Cancer Research and Treatments
Papers in
- Oncology 18
- Cancer Treatment and Pharmacology 4
- Lung Cancer Research Studies 3
- Global Cancer Incidence and Screening 3
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Beverly Plunkett (1 shared paper)Steven J. Kuerbitz (1 shared paper)Michael B. Kastan (1 shared paper)Ekatherine Asatiani (1 shared paper)Sameer A. Parikh (1 shared paper)Aaron D. Schimmer (1 shared paper)Hagop M. Kantarjian (1 shared paper)Elliott F. Winton (1 shared paper)
- Journals
- Journal of Clinical Oncology (12 papers)Blood (3 papers)Frontiers in Oncology (2 papers)Lung Cancer (2 papers)Frontiers in Public Health (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
William Walsh
29 papers receiving 1.8k citations
William Walsh's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 1.2k
- Biotechnology 346
- Cancer Research 304
- Molecular Biology 1.1k
- Pathology and Forensic Medicine 134
Countries citing papers authored by William Walsh
This map shows the geographic impact of William Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Walsh more than expected).
Fields of papers citing papers by William Walsh
This network shows the impact of papers produced by William Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Walsh. The network helps show where William Walsh may publish in the future.
Co-authors
The 25 scholars most cited alongside William Walsh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Hit paper breakdown → | 1992 | 1659 |
| 2 | 2010 | 76 | |
| 3 | 2018 | 25 | |
| 4 | 2006 | 19 | |
| 5 | 2018 | 17 | |
| 6 | 2007 | 14 | |
| 7 | 2017 | 12 | |
| 8 | 2013 | 9 | |
| 9 | 2004 | 9 | |
| 10 | 2021 | 9 | |
| 11 | 2018 | 8 | |
| 12 | 2020 | 7 | |
| 13 | 2007 | 6 | |
| 14 | 2013 | 6 | |
| 15 | 2018 | 6 | |
| 16 | 2017 | 5 | |
| 17 | 2020 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2006 | 2 | |
| 20 | 2009 | 2 |
About William Walsh
William Walsh is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Immunology and Surgery, having authored 32 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (4 papers), Multiple and Secondary Primary Cancers (3 papers), Acute Myeloid Leukemia Research (3 papers), Lung Cancer Research Studies (3 papers), Immunotherapy and Immune Responses (3 papers) and Global Cancer Incidence and Screening (3 papers). The work is most often cited by research in Oncology (1.2k citations), Biotechnology (346 citations), Cancer Research (304 citations), Molecular Biology (1.1k citations) and Pathology and Forensic Medicine (134 citations). William Walsh has collaborated with scholars based in United States and Canada. Frequent co-authors include Beverly Plunkett, Steven J. Kuerbitz, Michael B. Kastan, Ekatherine Asatiani, Sameer A. Parikh, Aaron D. Schimmer, Hagop M. Kantarjian, Elliott F. Winton, Khaled El‐Shami and Srđan Verstovšek. Their work appears in journals such as Journal of Clinical Oncology, Blood, Frontiers in Oncology, Lung Cancer and Frontiers in Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.